Analysts' Actions: LSI MRVL PPG UAL

NEW YORK (TheStreet) -- CHANGE IN RATINGS

American Gas Partners ( APU) was downgraded to Hold at TheStreet Ratings.

BCD Semiconductor ( BCDS) was upgraded to Hold at TheStreet Ratings.

CTS ( CTS) was upgraded to Buy at TheStreet Ratings.

Eldorado Gold ( EGO) was downgraded to Hold at TheStreet Ratings.

1-800-Flowers ( FLWS)was upgraded to Buy at TheStreet Ratings.

Zhongpin ( HOGS) was upgraded to Buy at TheStreet Ratings.

Kohl's ( KSS) was downgraded to Hold at TheStreet ratings.

LSI ( LSI) was initiated with buy rating at Wunderlich. $9 price target. Flash business should drive growth in the coming quarters, Wunderlich said.

Marvell ( MRVL) was initiated with a hold rating at Wunderlich. $9 price target. Company lacks near-term visibility and leadership, Wunderlich said.

PCTEL ( PCTI) was upgrade to Buy at TheStreet Ratings.

Universal Forest Products ( UFPI) was upgraded to Buy at TheStreet Ratings.

Stock Comments / EPS Changes

PPG Industries ( PPG) numbers were raised at Jefferies. Shares are now seen reaching $151. Estimates were also raised on adjusted estimates for likely split-off, Jefferies said. Buy rating.

United Continental ( UAL) estimates were reduced through 2014 at Sterne Agee. Company is adding less capacity, Sterne Agee said. Buy rating and $35 price target.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says